(3R)-3-amino-3-phenylpropanamide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (3R)-3-amino-3-phenylpropanamide
• 化学式: C₉H₁₂N₂O
• 分子量: 164.207
• InChiKey: LWTUSLSPLDBOBT-MRVPVSSYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  69.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-{[3-(1H-pyrrolo[2,3-b]pyridin-4-ylamino)-thiophene-2-carbonyl]-amino}-pyrrolidine-1-carboxylic acid tert-butyl ester 、 (3R)-3-amino-3-phenylpropanamide 生成 3-(1H-pyrrolo[2,3-b]pyridin-4-ylamino)-thiophene-2-carboxylic acid ((R)-2-carbamoyl-1-phenyl-ethyl)-amide
  参考文献：
  名称：

  Novel Azaheterocyclic Compounds

  摘要：

  本发明提供了根据式(I)的新型取代的氮杂杂环化合物，其制备和用于治疗高增殖性疾病，如癌症。

  公开号：

  US20120277228A1
• 作为产物：
  描述：

  3-氨基肉桂腈 在 盐酸 、 水 、 sodium cyanoborohydride 作用下， 以 甲醇 、 乙醇 、 水 为溶剂， 反应 3.0h， 生成 (S)-3-amino-3-phenylpropanamide 、 (3S)-3-amino-3-phenylpropionitrile 、 (R)-3-amino-3-phenylpropanenitrile 、 (3R)-3-amino-3-phenylpropanamide
  参考文献：
  名称：

  Enantioselective biocatalytic hydrolysis of β-aminonitriles to β-amino-amides using Rhodococcus rhodochrous ATCC BAA-870

  摘要：

  A range of beta-aminonitriles (3-amino-3-phenylpropanenitrile and derivatives) were synthesised by reaction of various benzonitriles with acetonitrile and subsequent reduction of the resulting acrylonitrile products. These compounds were hydrolysed to the corresponding amides using the nitrile biocatalytic activity of Rhodococccus rhodochrous ATCC BAA-870. Results showed that the nitrile hydratase enzyme was enantioselective for these compounds, in particular 3-amino-3-p-tolylpropanenitrile and 3-amino-3-(4-methoxyphenyl)propanenitrile and the corresponding amides (up to 85% in one case). The reactions were performed at pH 9.0 after initial attempts at pH 7.0 were unsuccessful, most likely as a result of protonation of the 3-amino group at the lower pH. (C) 2012 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.molcatb.2011.12.005

文献信息

• [EN] NOVEL AZAHETEROCYCLIC COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS AZAHÉTÉROCYCLIQUES
  申请人：MERCK PATENT GMBH

  公开号：WO2011017009A1

  公开（公告）日：2011-02-10

  The invention provides novel substituted azaheterocyclic compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

  该发明提供了根据式（I）提供的新型取代的氮杂环化合物，其制备和用于治疗高增殖性疾病，如癌症。
• Novel Azaheterocyclic Compounds
  申请人：Sutton Amanda E.

  公开号：US20120277228A1

  公开（公告）日：2012-11-01

  The invention provides novel substituted azaheterocyclic compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

  本发明提供了根据式(I)的新型取代的氮杂杂环化合物，其制备和用于治疗高增殖性疾病，如癌症。
• Discovery of Nanomolar DCAF1 Small Molecule Ligands
  作者：Alice Shi Ming Li、Serah Kimani、Brian Wilson、Mahmoud Noureldin、Héctor González-Álvarez、Ahmed Mamai、Laurent Hoffer、John P. Guilinger、Ying Zhang、Moritz von Rechenberg、Jeremy S. Disch、Christopher J. Mulhern、Belinda L. Slakman、John W. Cuozzo、Aiping Dong、Gennady Poda、Mohammed Mohammed、Punit Saraon、Manish Mittal、Pratik Modh、Vaibhavi Rathod、Bhashant Patel、Suzanne Ackloo、Vijayaratnam Santhakumar、Magdalena M Szewczyk、Dalia Barsyte-Lovejoy、Cheryl H. Arrowsmith、Richard Marcellus、Marie-Aude Guié、Anthony D. Keefe、Peter J. Brown、Levon Halabelian、Rima Al-awar、Masoud Vedadi

  DOI：10.1021/acs.jmedchem.2c02132

  日期：——

  learning. This led to the discovery of a compound (Z1391232269) with an SPR KD of 11 μM. Structure-guided hit optimization led to the discovery of OICR-8268 (26e) with an SPR KD of 38 nM and cellular target engagement with EC50 of 10 μM as measured by cellular thermal shift assay (CETSA). OICR-8268 is an excellent tool compound to enable the development of next-generation DCAF1 ligands toward cancer therapeutics

  DCAF1 是两种不同 E3 连接酶（CRL4 DCAF1和 EDVP）的底物受体，在蛋白质降解中发挥着关键的生理作用，被认为是多种癌症的药物靶点。 DCAF1 拮抗剂可用于开发癌症和病毒治疗疗法。我们使用 DCAF1 的 WDR 结构域筛选包含 1140 亿个化合物的 DNA 编码库 (DEL)，并使用相似性搜索和机器学习识别候选化合物。由此发现了一种 SPR KD为11 μM 的化合物 (Z1391232269)。结构引导的命中优化导致 OICR-8268 ( 26e ) 的发现，通过细胞热位移测定 (CETSA) 测量，其 SPR K D为 38 nM，细胞靶标结合 EC 50为 10 μM。 OICR-8268 是一种出色的工具化合物，可用于开发用于癌症治疗的下一代 DCAF1 配体、进一步研究 DCAF1 在细胞中的功能以及开发基于 DCAF1 的 PROTAC。
• Highly enantioselective enzymatic resolution of aromatic β-amino acid amides with Pd-catalyzed racemization
  作者：Eunjeong Choi、Yunwoong Kim、Yangsoo Ahn、Jaiwook Park、Mahn-Joo Kim

  DOI：10.1016/j.tetasy.2013.09.022

  日期：2013.12

  The kinetic resolution of an aromatic beta-amino acid amide 3a-d via N-acylation was explored with two lipases, Candida antarctica lipase A (CALA) and Pseudomonas stutzeri lipase (PSL). The PSL-catalyzed resolution proceeded with excellent enantioselectivity (E = >400) to give both acylated products and unreacted substrates in enantiopure forms. Three additional aromatic beta-amino acid amides 3b-d were also resolved by PSL with a high level of enantioselectivity (E = >200). The PSL-catalyzed resolution of 3a was coupled with a Pd-catalyzed racemization to obtain enantiopure N-acylated product (R)-4a (>99% ee) in high yield (90%). (C) 2013 Elsevier Ltd. All rights reserved.
• NOVEL AZAHETEROCYCLIC COMPOUNDS
  申请人：Merck Patent GmbH

  公开号：EP2462141B1

  公开（公告）日：2017-09-27